Study Finds Majority Of CBD Products Are Not As Advertised

2020 FDA Study Finds A Majority Of CBD Products Are Not As Advertised

2020 FDA Study Finds A Majority Of CBD Products Are Not As Advertised

The U.S. Food and Drug Administration recently conducted a study on CBD infused products available for over the counter purchase in the United States. The study focused primarily on testing the contents of these varieties of CBD tinctures, edibles, and supplements to determine the validity of their labeling. What they found as a result of this study may shock you.

The FDA in its findings acknowledged and emphasized that it “recognizes the significant public interest in CBD products.” In all, the FDA tested 147 products comprised of various:

– tinctures
– oils
– capsules
– edibles
– drinks
– pet products

Not all were labeled as having CBD, but 138 contained at least some amount of the cannabinoid. The products chosen for the study were chosen at random, and were gathered using the internet, as well as firms that have previously received FDA warning letters for making health claims about CBD, industry event participants, and advertisers in trade journals.

The federal agency repeatedly noted in its findings that the testing was from a limited sample size and that no definitive conclusions could be drawn, but “supports the need for” long-term study.

Findings

The U.S. Food and Drug Administration was shocked to find that a majority of the products in one way or another were mislabeled, and or did not contain the amount or proportion of ingredients advertised. The FDA consistently found products containing far less or more CBD than advertised, and in some instances they found THC that had not been advertised to the customer.

FDA 2020: Advertised CBD Amounts Compared to Actual CBD Amounts

102 FDA Tested CBD Products

Less than 80% of amount of CBD advertised – 18 products

Within 20% of amount of CBD advertised – 46 products

More than 120% of amount of CBD advertised – 38 products

These results were included in an undated letter to Congress in early July of 2020. An FDA spokesman confirmed the letter but declined to comment on the findings. Although, the letter boldly states that “there are (still) many questions about the characteristics of currently marketed CBD products.”

Industry reaction

This report did not come to the surprise of hemp producers and advocates, those in the industry called the FDA review a need for alarm but also reaffirming, because many have in the past called for increased federal oversight of the industry.

Marielle Weintraub, the head of the U.S. Hemp Authority, a self-regulatory agency, responded saying “Hemp is an industry that holds itself to the highest standards, and as a whole we would like to rid the marketplace of the bad players who improperly label products and put consumers at risk,” Weintraub stressed that “Today’s report emphasizes what we have been arguing for years: FDA needs to regulate hemp and CBD products.”

Apple Cider Vinegar + Nano CBD GummiesLooking For High Quality Doctor-Formulated, Organic US CBD Hemp Oil Products?

Then look no further than the fine folks at Being Hemp! All Being Hemp CBD products are crafted in facilities that are GMP certified to ensure consistency, safety, quality control and reliability for every batch.

Being Hemp only uses the most reputable third-party testing labs to verify all product ingredients and potencies for every batch. Click here & check out all the Certificate of Analysis (COA).

We love Being Hemp’s Apple Cider Vinegar + Nano CBD Gummies!

Remember, check the Certificate of Analysis (COA) of any CBD products before you purchase them! Usually you can find a QR code or some other type of link to the COA on the product label and you can confirm its authenticity. If there’s no COA then we highly recommend that you avoid purchasing it.

You May Also Like